Wray and Mayorkas Were Set to Testify Today. They Didn't Show Up.
Matt Gaetz Withdraws Attorney General Nomination
Bucks County Dem Apologizes for Trying to Steal the PA Senate Race
Jon Stewart Rips Into Dems for Their Obnoxious Sugar-Coating of the 2024 Election
Homan Says They'll 'Absolutely' Use Land Texas Offered for Deportation Operation
For the First Time in State History, California Voters Say No to Another...
Breaking: ICC Issues Arrest Warrants for Netanyahu, Gallant
Begich Flips Alaska's Lone House Seat for Republicans
It's Hard to Believe the US Needs Legislation This GOP Senator Just Introduced,...
The System Finally Worked for Laken Riley -- Long After Her Entirely Avoidable...
Gun Ownership Is Growing Among This Group of Americans
We’ve Got an Update on Jussie Smollett…and You’re Not Going to Like It
Here’s How Many FCC Complaints Were Filed After Kamala Harris’ 'SNL' Appearance
By the Numbers: Trump's Extraordinary Gains Among Latinos, From Texas to...California?
John Oliver Defended Transgender Athletes Competing in Women’s Sports. JK Rowling Responde...
Tipsheet

Moderna Announces Development of Combination COVID-19 Booster and Flu Vaccine

AP Photo/Rogelio D. Solis

Moderna announced on Thursday it had begun development for a potential single-dose vaccine that is a combination of a Wuhan coronavirus vaccine booster shot and seasonal flu shot. 

Advertisement

In a press release published Thursday, Moderna CEO Stephane Bancel announced the new development and shared the progress of other programs the company is working on, such as their “cancer vaccine.” 

“Today we are announcing the first step in our novel respiratory vaccine program with the development of a single dose vaccine that combines a booster against COVID-19 and a booster against flu,” Bancel said in a statement. “We are making progress on enrolling patients in our rare disease programs, and we are fully enrolled in our personalized cancer vaccine trial. We believe this is just the beginning of a new age of information-based medicines.”

As we previously reported, Moderna informed investors and analysts last month that the company was planning for a booster COVID-19 shot in addition to its already-existing two-dose mRNA vaccine shot. As of right now, the Moderna COVID-19 vaccine was granted Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) to be administered to prevent the spread of COVID-19. However, the vaccine has not been fully approved by the FDA.

Advertisement

“We are pleased that our COVID-19 vaccine is showing durable efficacy of 93% through six months, but recognize that the Delta variant is a significant new threat so we must remain vigilant,” Bancel said in a statement last month announcing plans for a potential booster shot. In the statement, Bancel also said Moderna is “looking forward towards our vision of a single dose annual booster that provides protection against COVID-19, flu and RSV for adults.”

Perhaps that vision could be on the horizon with this hybrid coronavirus/flu vaccine in the works. This week, however, World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus reiterated his call for a halt on COVID-19 booster shots through the end of the year. Moderna has not revealed when it plans to have the booster shot completed.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement